Ethinylestradiol/levonorgestrel - NobelpharmaAlternative Names: NPC-16
Latest Information Update: 19 Feb 2015
At a glance
- Originator Nobelpharma
- Class Alkylated estrogenic steroids; Contraceptives; Hormonal replacements; Norpregnanes; Norpregnatrienes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Female genital diseases
Most Recent Events
- 19 Feb 2015 Nobelpharma plans a phase III trial for Dysmenorrhoea in Japan (NCT02362711)